Navigation Links
Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
Date:5/1/2012

INDIANAPOLIS, May 1, 2012 /PRNewswire/ -- The Diagnostic Marketing Association (DxMA), serving marketing, regulatory and medical affairs professionals in the diagnostic and device market segments, today presented its 2011 Marketer of the Year Award to Cepheid (Nasdaq: CPHD), a leading molecular diagnostics company. Presented at the annual DxMA Global Marketing Summit, the award recognizes innovation by marketers seeking to highlight their company and products at the leading edge of the diagnostic industry.

Cepheid was selected for its "Art Meets Innovation" campaign.  To unveil its redesigned GeneXpert® Systems at the 2011 American Association of Clinical Chemistry and Clinical Lab Expo, Cepheid partnered with Paul Jr. Designs, a world-renowned builder of custom motorcycles, to build a custom bike themed on its new GeneXpert Systems and molecular diagnostic testing. The live unveiling event was filmed for the popular Discovery Channel show American Chopper. The epic bike had to be "as cutting edge and innovative, yet as elegant as our technology," said Cepheid CEO John Bishop. An entire marketing campaign, including a road show with the bike, was developed around the 'Art Meets Innovation' theme.

"The Marketer of the Year Award is the highest accolade DxMA offers for diagnostic companies," said Robter Speziale, President DxMA. "It recognizes outstanding work that raises the bar in diagnostics marketing. In a crowded field, Cepheid stood out with its 'Art Meets Innovation' marketing campaign, by demonstrating the strongest commitment to marketing innovation, boldness and execution that symbolizes both Cepheid and its GeneXpert on-demand molecular testing technology."

To learn more about the Cepheid Bike and GeneXpert campaign, visit http://www.cepheid.com/cepheid-bike/.

About DxMA (Diagnostic Marketing Association)

The DxMA builds diagnostic industry leadership by providing knowledge and opportunities for professional development and the exchange of ideas. We serve marketing, regulatory compliance and medical affairs professionals who have devoted their careers to the diagnostics and device market segments. Members benefit from continued education and insight, networking with marketers from leading diagnostic companies and service providers, and the AACC seminar and DxMA Global Marketing Summit. For more information on the DxMA, visit www.dxma.org.

About Cepheid

Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Contact
Debra Harrsch
Brandwidth Solutions LLC
215 997-8575
Dharrsch@brandwidthsolutions.com


'/>"/>
SOURCE The Diagnostic Marketing Association
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
2. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
3. VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008
4. Exosome Diagnostics Announces Additions to Management Team
5. Pathwork Diagnostics Closes $20M Financing
6. Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc.
7. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
8. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
9. Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
10. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
11. Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):